Microstructural White Matter Changes, Not Hippocampal Atrophy, Detect Early Amnestic Mild Cognitive Impairment

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Zhuang, Lin ^a   Sachdev, Perminder S ^a,b   Trollor, Julian N ^a,c   Reppermund, Simone ^a   Kochan, Nicole A ^a,b   Brodaty, Henry ^a   Wen, Wei ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BRAIN ATROPHY; BRAIN FORNIX; BRAIN RADIOGRAPHY; BRAIN SIZE; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; DISEASE ASSOCIATION; EARLY DIAGNOSIS; EPISODIC MEMORY; FEMALE; FOLLOW UP; FRACTIONAL ANISOTROPY; HIPPOCAMPUS; HUMAN; INFERIOR LONGITUDINAL BUNDLE; LIMBIC CORTEX; MAJOR CLINICAL STUDY; MALE; MICROMORPHOLOGY; MILD COGNITIVE IMPAIRMENT; NERVE TRACT; NEUROIMAGING; PARAHIPPOCAMPAL CINGULUM; PARAHIPPOCAMPAL GYRUS; PYRAMIDAL TRACT; SUPERIOR LONGITUDINAL BUNDLE; UNCINATE FASCICULUS; WHITE MATTER INJURY; AMNESIA; ATROPHY; BRAIN; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; THREE DIMENSIONAL IMAGING; TIME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMNESIA; ATROPHY; BRAIN; DIFFUSION TENSOR IMAGING; FEMALE; HIPPOCAMPUS; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; MEMORY, EPISODIC; MILD COGNITIVE IMPAIRMENT; ORGAN SIZE; TIME FACTORS;

EID: 84875047852     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058887     Document Type: Article

References (64)

1. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, et al. (2001) Current concepts in mild cognitive impairment. Arch Neurol 58: 1985-1992.
2. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, et al. (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56: 303-308.
3. Fischer P, Jungwirth S, Zehetmayer S, Weissgram S, Hoenigschnabl S, et al. (2007) Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology 68: 288-291.
4. Geslani DM, Tierney MC, Herrmann N, Szalai JP, (2005) Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer's disease. Dement Geriatr Cogn Disord 19: 383-389.
5. Ganguli M, Dodge HH, Shen C, DeKosky ST, (2004) Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology 63: 115-121.
6. Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, et al. (2004) Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Archives of Neurology 61: 59-66.
7. Yaffe K, Petersen RC, Lindquist K, Kramer J, Miller B, (2006) Subtype of mild cognitive impairment and progression to dementia and death. Dement Geriatr Cogn Disord 22: 312-319.
8. Busse A, Hensel A, Guhne U, Angermeyer MC, Riedel-Heller SG, (2006) Mild cognitive impairment: long-term course of four clinical subtypes. Neurology 67: 2176-2185.
9. Pike KE, Savage G, Villemagne VL, Ng S, Moss SA, et al. (2007) Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain 130: 2837-2844.
10. Jack CR, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, et al. (2009) Serial PIB and MRI in normal, mild cognitive impairment and Alzheimers disease: implications for sequence of pathological events in Alzheimers disease. Brain 132: 1355-1365.
11. Whitwell JL, Przybelski SA, Weigand SD, Knopman DS, Boeve BF, et al. (2007) 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain 130: 1777-1786.
12. Devanand DP, Pradhaban G, Liu X, Khandji A, De Santi S, et al. (2007) Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology 68: 828-836.
13. Duara R, Loewenstein DA, Potter E, Appel J, Greig MT, et al. (2008) Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease. Neurology 71: 1986-1992.
14. Stoub TR, Bulgakova M, Leurgans S, Bennett DA, Fleischman D, et al. (2005) MRI predictors of risk of incident Alzheimer disease: a longitudinal study. Neurology 64: 1520-1524.
15. Dickerson BC, Goncharova I, Sullivan MP, Forchetti C, Wilson RS, et al. (2001) MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol Aging 22: 747-754.
16. Englund E, (1998) Neuropathology of WM changes in Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 9Suppl 1: 6-12.
17. Brun A, Englund E, (1986) A WM disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 19: 253-262.
18. Pierpaoli C, Barnett A, Pajevic S, Chen R, Penix LR, et al. (2001) Water diffusion changes in Wallerian degeneration and their dependence on WM architecture. Neuroimage 13: 1174-1185.
19. Selnes P, Fjell AM, Gjerstad L, Bjornerud A, Wallin A, et al. (2012) WM imaging changes in subjective and mild cognitive impairment. Alzheimers Dement 8: S112-121.
20. Agosta F, Pievani M, Sala S, Geroldi C, Galluzzi S, et al. (2011) WM damage in Alzheimer disease and its relationship to gray matter atrophy. Radiology 258: 853-863.
21. Zhuang L, Sachdev PS, Trollor JN, Kochan NA, Reppermund S, et al. (2012) Microstructural WM changes in cognitively normal individuals at risk of amnestic MCI. Neurology 79: 748-754.
22. Brickman AM, Provenzano FA, Muraskin J, Manly JJ, Blum S, et al. (2012) Regional WM Hyperintensity Volume, Not Hippocampal Atrophy, Predicts Incident Alzheimer Disease in the Community. Arch Neurol: 1-7.
23. de la Monte SM, (1989) Quantitation of cerebral atrophy in preclinical and end-stage Alzheimer's disease. Ann Neurol 25: 450-459.
24. Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, et al. (2005) Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307: 1282-1288.
25. Desai MK, Sudol KL, Janelsins MC, Mastrangelo MA, Frazer ME, et al. (2009) Triple-transgenic Alzheimer's disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology. Glia 57: 54-65.
26. Bozoki AC, Korolev IO, Davis NC, Hoisington LA, Berger KL (In press) Disruption of limbic WM pathways in mild cognitive impairment and Alzheimer's disease: A DTI/FDG-PET Study. Hum Brain Mapp.
27. Kiuchi K, Morikawa M, Taoka T, Nagashima T, Yamauchi T, et al. (2009) Abnormalities of the uncinate fasciculus and posterior cingulate fasciculus in mild cognitive impairment and early Alzheimer's disease: a diffusion tensor tractography study. Brain Res 1287: 184-191.
28. Pievani M, Agosta F, Pagani E, Canu E, Sala S, et al. (2010) Assessment of WM tract damage in mild cognitive impairment and Alzheimer's disease. Hum Brain Mapp 31: 1862-1875.
29. Aggleton JP, McMackin D, Carpenter K, Hornak J, Kapur N, et al. (2000) Differential cognitive effects of colloid cysts in the third ventricle that spare or compromise the fornix. Brain 123: 800-815.
30. Valenstein E, Bowers D, Verfaellie M, Heilman KM, Day A, et al. (1987) Retrosplenial Amnesia. Brain 110: 1631-1646.
31. Levine B, Black SE, Cabeza R, Sinden M, Mcintosh AR, et al. (1998) Episodic memory and the self in a case of isolated retrograde amnesia. Brain 121: 1951-1973.
32. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, et al. (2004) Mild cognitive impairment- beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine 256: 240-246.
33. Hindmarch I, Lehfeld H, de Jongh P, Erzigkeit H, (1998) The Bayer Activities of Daily Living Scale (B-ADL). Dement Geriatr Cogn Disord 9Suppl 2: 20-26.
34. Wechsler D (1997) Wechsler Memory Scale, 3rd edition. San Antonio: The Psychological Corporation.
35. Strauss E, Sherman E, Spreen O (2006) A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary, 3rd edition. New York: Oxford University Press.
36. Wakana S, Caprihan A, Panzenboeck MM, Fallon JH, Perry M, et al. (2007) Reproducibility of quantitative tractography methods applied to cerebral white matter. Neuroimage 36: 630-644.
37. Wen W, Sachdev P, (2004) The topography of WM hyperintensities on brain MRI in healthy 60-to 64-year-old individuals. NEUROIMAGE 22: 144-154.
38. Wen W, Sachdev PS, Li JJ, Chen XH, Anstey KJ, (2009) WM Hyperintensities in the Forties: Their Prevalence and Topography in an Epidemiological Sample Aged 44-48. HUMAN BRAIN MAPPING 30: 1155-1167.
39. Patenaude B, Smith SM, Kennedy DN, Jenkinson M, (2011) A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 56: 907-922.
40. Jenkinson M, Smith S, (2001) A global optimisation method for robust affine registration of brain images. Med Image Anal 5: 143-156.
41. Ringman JM, O'Neill J, Geschwind D, Medina L, Apostolova LG, et al. (2007) Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations. Brain 130: 1767-1776.
42. Gold BT, Powell DK, Andersen AH, Smith CD, (2010) Alterations in multiple measures of WM integrity in normal women at high risk for Alzheimer's disease. Neuroimage 52: 1487-1494.
43. Acosta-Cabronero J, Williams GB, Pengas G, Nestor PJ, (2010) Absolute diffusivities define the landscape of WM degeneration in Alzheimer's disease. Brain 133: 529-539.
44. Song SK, Sun SW, Ramsbottom MJ, Chang C, Russell J, et al. (2002) Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 17: 1429-1436.
45. Song SK, Yoshino J, Le TQ, Lin SJ, Sun SW, et al. (2005) Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 26: 132-140.
46. Sun SW, Liang HF, Cross AH, Song SK, (2008) Evolving Wallerian degeneration after transient retinal ischemia in mice characterized by diffusion tensor imaging. Neuroimage 40: 1-10.
47. Sun SW, Liang HF, Trinkaus K, Cross AH, Armstrong RC, et al. (2006) Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum. Magn Reson Med 55: 302-308.
48. Beaulieu C, (2002) The basis of anisotropic water diffusion in the nervous system- a technical review. NMR Biomed 15: 435-455.
49. West MJ, Coleman PD, Flood DG, Troncoso JC, (1994) Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 344: 769-772.
50. Lee DY, Fletcher E, Carmichael OT, Singh B, Mungas D, et al. (2012) Sub-Regional Hippocampal Injury is Associated with Fornix Degeneration in Alzheimer's Disease. Frontiers in aging neuroscience 4: 1.
51. Heise V, Filippini N, Ebmeier KP, Mackay CE, (2011) The APOE varepsilon4 allele modulates brain WM integrity in healthy adults. Mol Psychiatry 16: 908-916.
52. Moudgil SS, Azzouz M, Al-Azzaz A, Haut M, Gutmann L, (2000) Amnesia due to fornix infarction. Stroke 31: 1418-1419.
53. Hattingen E, Rathert J, Raabe A, Anjorin A, Lanfermann H, et al. (2007) Diffusion tensor tracking of fornix infarction. J Neurol Neurosurg Psychiatry 78: 655-656.
54. Honea RA, Vidoni E, Harsha A, Burns JM, (2009) Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study. J Alzheimers Dis 18: 553-564.
55. Persson J, Lind J, Larsson A, Ingvar M, Cruts M, et al. (2006) Altered brain WM integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD? Neurology 66: 1029-1033.
56. Blacker D, Haines JL, Rodes L, Terwedow H, Go RCP, et al. (1997) ApoE-4 and age at onset of Alzheimer's disease: The NIMH genetics initiative. Neurology 48: 139-147.
57. Salo A, Ylikoski R, Verkkoniemi A, Polvikoski T, Juva K, et al. (2001) Does apolipoprotein E influence learning and memory in the nondemented oldest old? International Psychogeriatrics 13: 451-459.
58. Dickerson B, Stoub T, Shah R, Sperling R, Killiany R, et al. (2011) Alzheimer-Signature MRI Biomarker Predicts AD Dementia in Cognitively Normal Adults. Neurology 76: A659-A659.
59. Desai MK, Mastrangelo MA, Ryan DA, Sudol KL, Narrow WC, et al. (2010) Early oligodendrocyte/myelin pathology in Alzheimer's disease mice constitutes a novel therapeutic target. Am J Pathol 177: 1422-1435.
60. Niewiadomska G, Baksalerska-Pazera M, Riedel G, (2005) Altered cellular distribution of phospho-tau proteins coincides with impaired retrograde axonal transport in neurons of aged rats. Ann N Y Acad Sci 1048: 287-295.
61. Murer MG, Yan Q, Raisman-Vozari R, (2001) Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 63: 71-124.
62. Erickson KI, Prakash RS, Voss MW, Chaddock L, Heo S, et al. (2010) Brain-Derived Neurotrophic Factor Is Associated with Age-Related Decline in Hippocampal Volume. Journal of Neuroscience 30: 5368-5375.
63. Belarbi K, Burnouf S, Fernandez-Gomez FJ, Desmercieres J, Troquier L, et al. (2011) Loss of Medial Septum Cholinergic Neurons in THY-Tau22 Mouse Model: What Links with tau Pathology? Current Alzheimer Research 8: 633-638.
64. Zhang H, Trollor JN, Wen W, Zhu W, Crawford JD, et al. (2011) Grey matter atrophy of basal forebrain and hippocampus in mild cognitive impairment. J Neurol Neurosurg Psychiatry 82: 487-493.